Oisín Biotechnologies Announces First Close of $15 Million Series A Financing Round to Advance Therapies for Age-Related Diseases
– AbbVie Ventures Leads the Round July 24, 2024 05:00 AM Pacific Daylight Time SEATTLE–(BUSINESS WIRE)–Oisín Biotechnologies (Oisín), a privately held biotechnology company focused on mitigating the effects of age-related diseases, today announced the first…